New pill could help diabetic patients see better
NCT ID NCT07199777
Summary
This study is testing an oral medication called SNP318 for people with diabetic macular edema, a condition where fluid builds up in the eye and causes vision problems. About 60 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces eye swelling and improves vision. The goal is to find a new treatment option that doesn't require eye injections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.